Persistent Pulmonary Hypertension: A Look Into the Future Therapy.

Area of Science:

• Neonatology
• Pediatric Cardiology
• Pulmonary Medicine

Background:

• Persistent pulmonary hypertension of the newborn (PPHN) is a critical lung disorder affecting neonatal systemic circulation.
• It is a leading cause of neonatal intensive care unit (NICU) admission, associated with significant morbidity and mortality.
• PPHN stems from complex, multifactorial etiologies.

Purpose of the Study:

• To review the pathogenesis of PPHN.
• To explore the clinical implications of PPHN, including heart failure.
• To analyze current and emerging diagnostic and therapeutic strategies for PPHN.

Main Methods:

• Literature review of existing research on PPHN.
• Analysis of diagnostic guidelines for PPHN.
• Evaluation of historical and novel treatment modalities for PPHN.

Main Results:

• PPHN presents with diverse hemodynamic changes in newborns.
• Established treatments include oxygen and surfactant therapy.
• Emerging treatments like magnesium sulfate and adenosine show promise.

Conclusions:

• Understanding PPHN pathogenesis is crucial for effective management.
• Comprehensive diagnostic approaches are essential for timely intervention.
• Ongoing research into novel therapies is vital for improving PPHN outcomes.